Rates of underuse of statins among cancer survivors versus controls: NHANES 2011–2016
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cancer Survivorship"
DOI: 10.1007/s11764-020-00865-z
Abstract: Purpose Cardiovascular disease (CVD) is a major non-cancer cause of mortality among cancer survivors, and statin therapy is the mainstay of cardiovascular risk management. However, little is known about adherence to statin therapy relative to… read more here.
Keywords: cancer survivors; underuse statins; among cancer; statin eligible ... See more keywords
Atherosclerotic cardiovascular disease events among statin eligible individuals with and without long-term healthy arterial aging.
Sign Up to like & getrecommendations! Published in 2021 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2021.03.018
Abstract: BACKGROUND AND AIMS A large proportion of statin eligible candidates have a baseline absence of coronary artery calcium (CAC) and low 10-year atherosclerotic cardiovascular disease (ASCVD) risk. We sought to determine the proportion of statin… read more here.
Keywords: long term; cac; healthy arterial; statin eligible ... See more keywords
Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study
Sign Up to like & getrecommendations! Published in 2018 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehx659
Abstract: Aims To identify individuals at high risk of atherosclerotic cardiovascular disease (ASCVD), who are not definite statin eligible according to the 2016 European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) guidelines, based on high concentrations of… read more here.
Keywords: cardiology; mmol 264; statin; statin eligible ... See more keywords